| 38th week of 2021 patent applcation highlights part 10 |
| Patent application number | Title | Published |
|---|
| 20210290584 | Implantable Drug Delivery Devices for Localized Drug Delivery | 2021-09-23 |
| 20210290585 | METHODS AND COMPOSITIONS FOR TREATING DISORDERS ASSOCIATED WITH CORTICO-HIPPOCAMPAL HYPERACTIVITY | 2021-09-23 |
| 20210290586 | ORAL DRUG DELIVERY COMPOSITION CONTAINING OXALIPLATIN AND METHOD FOR PREPARING SAME | 2021-09-23 |
| 20210290587 | TREATING IRON DEFICIENCY WITH FERRIC CARBOXYMALTOSE | 2021-09-23 |
| 20210290588 | USE OF gTso thal IN MANUFACTURING MEDICAMENT FOR PROMOTION OF MS-275 TO CROSS BLOOD-BRAIN BARRIER | 2021-09-23 |
| 20210290589 | METHODS OF PROVIDING SOLRIAMFETOL THERAPY TO SUBJECTS WITH IMPAIRED RENAL FUNCTION | 2021-09-23 |
| 20210290590 | METHODS OF TREATING SUBJECTS INFECTED WITH HIV | 2021-09-23 |
| 20210290591 | IMMUNOMODULATING UREA AZALIDES | 2021-09-23 |
| 20210290593 | USE OF SUSTAINED-RELEASE 5-HYDROXYTRYPTOPHAN IN TREATING GASTROINTESTINAL DISORDERS | 2021-09-23 |
| 20210290594 | BISDIAZABICYCLO COMPOUND FOR TREATMENT AND/OR PREVENTION OF HEPATITIS VIRUS-RELATED DISEASES OR DISORDERS | 2021-09-23 |
| 20210290595 | GFI1 INHIBITORS FOR THE TREATMENT OF HYPERGLYCEMIA | 2021-09-23 |
| 20210290596 | NEW USE OF ANGIOTENSIN II TYPE 2 RECEPTOR AGONIST | 2021-09-23 |
| 20210290597 | METHOD OF TREATING A CONDITION ASSOCIATED WITH NEURODEGENERATION USING INHIBITORS OF OAT3 | 2021-09-23 |
| 20210290598 | MEDICAMENT USEFUL FOR CARDIOVASCULAR DISEASE | 2021-09-23 |
| 20210290599 | USE OF RILUZOLE PRODRUGS TO TREAT ALZHEIMER'S DISEASE | 2021-09-23 |
| 20210290600 | Sphingosine Pathway Modulating Compounds For The Treatment Of Coronavirus Infection | 2021-09-23 |
| 20210290601 | METHODS AND COMPOSITIONS USING SYNTHETIC NANOCARRIERS COMPRISING IMMUNOSUPPRESSANT | 2021-09-23 |
| 20210290602 | COMPOSITIONS AND METHODS FOR TREATING ADULT-ONSET NEURONAL CEROID LIPOFUSCINOSIS (KUFS DISEASE) | 2021-09-23 |
| 20210290603 | METHODS FOR TREATING ACNE | 2021-09-23 |
| 20210290604 | COMPOUNDS FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE AND METHODS THEREOF | 2021-09-23 |
| 20210290605 | CYCLOOXYGENASE INHIBITOR AND CALCIUM CHANNEL ANTAGONIST COMPOSITIONS AND METHODS FOR USE IN UROLOGICAL PROCEDURES | 2021-09-23 |
| 20210290606 | METHOD TO PREVENT AND TREAT OSTEOARTHRITIS BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS | 2021-09-23 |
| 20210290607 | METHOD TO PREVENT AND TREAT MACULAR DEGENERATION BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS | 2021-09-23 |
| 20210290608 | CRYSTALLINE FORM OF A 4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUND | 2021-09-23 |
| 20210290609 | DEPOT ADMINISTRATION OF ILOPERIDONE | 2021-09-23 |
| 20210290610 | COMBINATION OF FXR AGONISTS | 2021-09-23 |
| 20210290611 | A BIFUNCTIONAL AGGREGATION-INDUCED EMISSION LUMINOGEN FOR MONITORING AND KILLING OF MULTIDRUG-RESISTANT BACTERIA | 2021-09-23 |
| 20210290612 | Methods of Treating PACS1 and PACS2 Syndromes | 2021-09-23 |
| 20210290613 | INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE | 2021-09-23 |
| 20210290614 | THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED DOCETAXEL AND A P-GP INHIBITOR FOR THE TREATMENT OF CANCER | 2021-09-23 |
| 20210290615 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | 2021-09-23 |
| 20210290616 | PROCASPASE COMBINATION THERAPY FOR GLIOBLASTOMA | 2021-09-23 |
| 20210290617 | OPHTHALMIC FORMULATIONS OF CETIRIZINE AND METHODS OF USE | 2021-09-23 |
| 20210290618 | PHARMACEUTICAL COMPOSITION COMPRISING DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND AS ACTIVE INGREDIENT | 2021-09-23 |
| 20210290619 | SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | 2021-09-23 |
| 20210290620 | Combinations of RET Inhibitors and mTORC1 Inhibitors and Uses Thereof for the Treatment of Cancer Mediated by Aberrant RET Activity | 2021-09-23 |
| 20210290621 | COMPOSITION FOR PREVENTING OR TREATING VASCULAR OR CARDIAC VALVULAR CALCIFICATION, CONTAINING THIAMINE DERIVATIVE | 2021-09-23 |
| 20210290622 | THERAPEUTIC USE OF AFATINIB IN CANCER | 2021-09-23 |
| 20210290623 | METHODS FOR TREATING OR PREVENTING CARDIOVASCULAR DISORDERS AND LOWERING RISK OF CARDIOVASCULAR EVENTS | 2021-09-23 |
| 20210290624 | METHODS OF TREATING CANCERS CHARACTERIZED BY A HIGH EXPRESSION LEVEL OF SPINDLE AND KINETOCHORE ASSOCIATED COMPLEX SUBUNIT 3 (SKA3) GENE | 2021-09-23 |
| 20210290625 | PYRIMIDINE DERIVATIVES FOR PREVENTION AND TREATMENT OF GRAM-NEGATIVE BACTERIAL INFECTION, CONTAMINATION AND FOULING | 2021-09-23 |
| 20210290626 | Advanced Formulations and Therapies for Treating Hard-to-Heal Wounds | 2021-09-23 |
| 20210290627 | PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE | 2021-09-23 |
| 20210290628 | COMPOUNDS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISORDERS | 2021-09-23 |
| 20210290629 | ACC INHIBITORS FOR USE IN TREATING MYCOBACTERIAL DISEASES | 2021-09-23 |
| 20210290630 | PHARMACEUTICAL COMPOSITION CONTAINING POORLY-SOLUBLE BASIC MEDICINE | 2021-09-23 |
| 20210290631 | PYRROLE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2021-09-23 |
| 20210290632 | HIGH-THROUGHPUT AUTOMATION OF ORGANOIDS FOR IDENTIFYING THERAPEUTIC STRATEGIES | 2021-09-23 |
| 20210290633 | COMBINATION FOR TREATING CANCER | 2021-09-23 |
| 20210290635 | TREATMENT OF CEREBRAL CAVERNOUS MALFORMATIONS AND CEREBRAL ANEURYSMS WITH RHO KINASE INHIBITORS | 2021-09-23 |
| 20210290636 | USE OF ESTETROL AS EMERGENCY CONTRACEPTIVE | 2021-09-23 |
| 20210290637 | SYSTEM FOR PROVIDING BIRTH CONTROL | 2021-09-23 |
| 20210290638 | COMPOSITION AND METHOD FOR PROMOTING PROSTATE HEALTH | 2021-09-23 |
| 20210290639 | IMMEDIATE RELEASE FORMULATION OF A TRIPLE COMBINATION OF ACTIVE PHARMACEUTICAL INGREDIENTS USEFUL IN THE TREATMENT OF POLYCYSTIC OVARY SYNDROME | 2021-09-23 |
| 20210290640 | A NOVEL AQUEOUS COMPOSITION WITH WATER INSOLUBLE VITAMINS | 2021-09-23 |
| 20210290641 | EP4 INHIBITORS AND USE THEREOF | 2021-09-23 |
| 20210290642 | IP AND IP ANALOGS DOSAGE REGIMENS FOR THE TREATMENT OF ECTOPIC CALCIFICATIONS | 2021-09-23 |
| 20210290643 | INOSITOL DERIVATIVES FOR USE IN PATHOLOGICAL CRYSTALLIZATION | 2021-09-23 |
| 20210290644 | COMPOUNDS AND METHODS FOR TREATING FUNGAL INFECTIONS | 2021-09-23 |
| 20210290645 | STING AGONISTS FOR TREATING BLADDER CANCER AND SOLID TUMORS | 2021-09-23 |
| 20210290646 | COMBINATION OF A GLYCOSYLATION INHIBITOR WITH ONE CAR CELL THERAPY FOR TREATING CANCER | 2021-09-23 |
| 20210290647 | COMPOSITIONS FOR ORAL CANCER OR AN OROPHARYNGEAL CANCER | 2021-09-23 |
| 20210290648 | Potentiation of B-Lactam Antibiotics and B-Lactam/B-Lactamase Inhibitor Combinations Against Multidrug and Extensively Drug-Resistant Pseudomonas Aeruginosa Using Non-Ribosomal Tobramycin-Cyclam Conjugates | 2021-09-23 |
| 20210290649 | Method of Preventing and Treating COVID-19 Infection | 2021-09-23 |
| 20210290650 | METHODS OF TREATING COVID-19 INFECTION | 2021-09-23 |
| 20210290651 | METHODS OF TREATING VIRAL INFECTIONS USING INHIBITORS OF NUCLEOTIDE SYNTHESIS PATHWAYS | 2021-09-23 |
| 20210290652 | SEQUENTIAL TREATMENT OF CANCERS USING 6-THIO-dG, CHECKPOINT INHIBITORS AND RADIATION THERAPY | 2021-09-23 |
| 20210290653 | MODULATION OF LNC05 EXPRESSION | 2021-09-23 |
| 20210290654 | ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA | 2021-09-23 |
| 20210290655 | HEALTH BENEFITING COMPOSITIONS OF DAILY SUPPLEMENT AND METHODS OF USE THEREOF | 2021-09-23 |
| 20210290656 | Antisense Compositions and Methods of Making and Using Same | 2021-09-23 |
| 20210290657 | Sulfated Glycosaminoglycan Biomaterials as Proteoglycan Mimics | 2021-09-23 |
| 20210290658 | HIGHLY SULFATED FUCANS FOR THE TREATMENT OF FIBROUS ADHESIONS | 2021-09-23 |
| 20210290659 | HIGHLY PURIFIED RICANS FOR THE TREATMENT OF FIBROUS ADHESIONS | 2021-09-23 |
| 20210290660 | HIGHLY PURIFIED AND/OR MODIFIED FUCAN COMPOSITIONS FOR THE TREATMENT OF FIBROUS ADHESIONS | 2021-09-23 |
| 20210290661 | IMMUNE MODIFYING PARTICLES FOR THE TREATMENT OF CANCER | 2021-09-23 |
| 20210290662 | METHODS OF TREATING UPPER GASTROINTESTINAL DISORDERS IN PPI REFRACTORY GERD | 2021-09-23 |
| 20210290663 | NITRITE FORMULATIONS AND THEIR USE AS NITRIC OXIDE PRODRUGS | 2021-09-23 |
| 20210290664 | DRUG THERAPY TO INHIBIT CHEMOTHERAPY-INDUCED ADVERSE EFFECTS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTICS, SCREENING TECHNIQUES AND KITS | 2021-09-23 |
| 20210290665 | TOPICAL COMPOSITION FOR TREATMENT OF PAIN AND SYMPTOMS ASSOCIATED WITH RHINOSINUSITIS, METHOD OF MAKING, AND METHOD OF USE | 2021-09-23 |
| 20210290666 | ANTIMICROBIAL and ANTI-INFLAMMATORY COMPOSITION | 2021-09-23 |
| 20210290667 | Mutant Bordetella Strains and Methods of Use | 2021-09-23 |
| 20210290668 | TOPICAL COMPOSITION FOR USE IN THE TREATMENT OF BURNS | 2021-09-23 |
| 20210290669 | METHODS AND TREATMENT OF TRAUMA ADVERSE EVENTS WITH OXYGEN REDUCED BLOOD | 2021-09-23 |
| 20210290670 | METHODS OF TREATING OR PREVENTING ALZHEIMER'S DISEASE AND ASSOCIATED CONDITIONS | 2021-09-23 |
| 20210290671 | ANTI-AGEING PHARMACEUTICAL PREPARATION | 2021-09-23 |
| 20210290672 | REGULATION OF TUMOR-ASSOCIATED T CELLS | 2021-09-23 |
| 20210290673 | Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof | 2021-09-23 |
| 20210290674 | METHODS FOR TREATING MYELOID MALIGNANCIES | 2021-09-23 |
| 20210290675 | MICROFLUIDIC METHODS FOR THE PREPARATION OF CELLS | 2021-09-23 |
| 20210290676 | IMPROVING THE EFFICACY AND SAFETY OF ADOPTIVE CELLULAR THERAPIES | 2021-09-23 |
| 20210290677 | METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF ANTAGONIST | 2021-09-23 |
| 20210290678 | ANTI-PTK7 IMMUNE CELL CANCER THERAPY | 2021-09-23 |
| 20210290679 | Coordinating Gene Expression Using RNA Destabilizing Elements | 2021-09-23 |
| 20210290680 | METHODS AND COMPOSITIONS FOR MODULATING CELLULAR AGING | 2021-09-23 |
| 20210290681 | TREATMENT OF DISEASE BASED ON IMMUNE CELL SEQUENCING | 2021-09-23 |
| 20210290682 | Functionalized Erythroid Cells | 2021-09-23 |
| 20210290683 | PLATELET LYSATE COMPOSITIONS AND USES THEREOF | 2021-09-23 |
| 20210290684 | Methods for Treating and/or Preventing Graft-Versus-Host Disease and/or Diffuse Alveolar Hemorrhage and/or Veno-Occlusive Disease Associated with Hematopoietic Stem Cell Transplant | 2021-09-23 |
| 20210290685 | METHODS FOR GENE MODIFICATION OF HEMATOPOIETIC CELLS | 2021-09-23 |
